BNTC
Benitec Biopharma Ltd
9.20$
+2.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.6% | 97.4% | 95.8% | 99.0% | 99.4% | 99.6% | 98.9% | 98.9% | 99.0% | 99.4% | 99.5% | 99.5% | |
| 95.6% | 95.4% | 94.3% | 97.4% | 98.6% | 99.0% | 98.5% | 98.1% | 98.4% | 99.0% | 98.8% | 98.5% | |
| 95.6% | 95.4% | 94.3% | 97.4% | 98.6% | 99.0% | 98.5% | 98.1% | 98.4% | 99.0% | 98.8% | 98.5% | |
| 0.2% | 0.2% | 0.4% | 0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | |
| 0.0% | 0.1% | 0.0% | 0.1% | – | – | – | – | – | – | – | – | |
| 17.5% | 27.6% | 23.3% | 9.5% | 6.7% | 4.0% | 7.3% | 2.3% | 2.5% | 1.7% | 2.0% | 3.1% | |
| 16.8% | 26.9% | 22.9% | 9.4% | 6.6% | 3.9% | 6.7% | 1.8% | 2.1% | 1.5% | 1.8% | 2.9% | |
| 1.0% | 1.3% | 1.9% | 0.5% | 0.3% | 0.2% | 0.3% | 0.4% | 0.4% | 0.2% | 0.3% | 0.3% | |
| 5.6% | 12.3% | 5.4% | 2.6% | 1.3% | 0.7% | 0.4% | 0.2% | 0.3% | 0.5% | 0.3% | 0.5% | |
| 82.5% | 72.4% | 76.7% | 90.5% | 93.3% | 96.0% | 92.7% | 97.7% | 97.5% | 98.3% | 98.0% | 96.9% | |
| -642.6% | -846.0% | -1,232.9% | -364.4% | -284.0% | -256.3% | -201.5% | -229.1% | -247.0% | -130.6% | -139.5% | -149.9% | |
| 31.9% | 48.3% | 69.8% | 19.3% | 15.5% | 27.9% | 36.7% | 36.4% | 43.2% | 24.1% | 26.4% | 25.5% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.